TBIO logo

Telesis Bio, Inc. (TBIO)

Profile

Full Name

Telesis Bio, Inc.

Ticker

NASDAQ: TBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

June 18, 2021

Indexes

Not included

Website

http://telesisbio.com

Employees

39

Key Details

Price

$0.30(0.00%)

Market cap

$531.87K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$27.51M(+0.27% YoY)

Annual EPS

-$29.52(+0.61% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.30
    TBIO price is $0.30

    30-Day Relative Volume

    0.00
    TBIO 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    0%
    TBIO {parameterFullLabel} has remained unchanged on Jul 11, 2025

    Price YTD change

    -25%
    TBIO price is down -25% since January 1st

    Price 1-year change

    -91.89%
    TBIO price is down -91.89% year-on-year

    Price 3-year change

    -99.1%
    TBIO price is down -99.1% over the past 3 years

    Price Range

    Price All-time high

    $462.60
    TBIO price is currently -99.94% below its historical high of $462.60

    Price 3-year low

    $0.01
    TBIO price is currently +2400.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $531.87K
    TBIO market capitalization is $531.87 thousand

    Market cap 3-year change

    -99.03%
    TBIO market capitalization is down -99.03% over the past 3 years

    Market cap All-time high

    $644.41M
    TBIO market capitalization is currently -99.92% below its historical high of $644.41 million

    Market cap sector rank

    3.06%
    TBIO market capitalization is higher than 3.06% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.07%
    TBIO shares outstanding is up +0.07% year-on-year

    Shares Outstanding 3-Year Change

    +8.12%
    TBIO shares outstanding is up +8.12% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -4.16
    TBIO beta is -4.16

    200-day SMA

    $0.73
    TBIO price is currently -58.70% below its 200-day simple moving average

    50-day SMA

    $0.15
    TBIO price is currently +104.64% above its 50-day simple moving average

    RSI

    71.34
    TBIO 14-day relative strength index is 71.34

    Volume

    0.00
    TBIO 30-day relative volume is 0.00

    ATR

    $0.01
    TBIO average true range is $0.01

    10-day Historical Volatility

    1003.99%
    TBIO 10-day historical volatility is 1003.99%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $27.51M
    TBIO annual revenue is $27.51 million

    Revenue Analysts estimate

    $9.20M
    TBIO annual revenue is currently +199.01% higher than the consensus analysts' forecast

    Revenue 1-year change

    +0.27%
    TBIO annual revenue is up +0.27% year-on-year

    Revenue Sector rank

    37.34%
    TBIO annual revenue is higher than 37.34% of companies in Healthcare sector

    EPS

    EPS

    -$29.52
    TBIO annual earnings per share is -$29.52

    EPS Analysts estimate

    -$24.95
    TBIO annual earnings per share is currently +18.32% higher than the consensus analysts' forecast

    EPS 1-year change

    +0.61%
    TBIO annual earnings per share is up +0.61% year-on-year

    EPS Sector rank

    5.91%
    TBIO annual earnings per share is higher than 5.91% of companies in Healthcare sector

    Profit

    Gross profit

    $16.95M
    TBIO annual gross profit is $16.95 million

    Gross margin

    61.62%
    TBIO annual gross profit margin is 61.62%

    Operating profit

    -$35.15M
    TBIO annual operating income is -$35.15 million

    Operating margin

    -127.78%
    TBIO annual operating profit margin is -127.78%

    Net income

    -$47.72M
    TBIO annual net profit is -$47.72 million

    Net margin

    -173.49%
    TBIO annual net profit margin is -173.49%

    Expenses

    Total expenses

    $62.66M
    TBIO annual total expenses is $62.66 million

    Operating expenses

    $52.10M
    TBIO annual total operating expenses is $52.10 million

    Cost of goods sold

    $10.56M
    TBIO annual cost of goods sold is $10.56 million

    Selling, general & administrative expenses

    $34.60M
    TBIO annual SGA is $34.60 million

    Depreciation and amortization

    $4.10M
    TBIO annual depreciation & amortization is $4.10 million

    Interest expense

    $3.10M
    TBIO annual interest expense is $3.10 million

    Income tax

    $24.00K
    TBIO annual income tax is $24.00 thousand

    EBIT & EBITDA

    EBIT

    -$44.59M
    TBIO annual earnings before interest & taxes is -$44.59 million

    EBITDA

    -$40.49M
    TBIO annual EBITDA is -$40.49 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $70.41M
    TBIO annual total assets is $70.41 million

    Non current assets

    $40.06M
    TBIO annual long term assets is $40.06 million

    Current assets

    $30.35M
    TBIO annual total current assets is $30.35 million

    Cash and cash equivalents

    $1.57M
    TBIO annual cash & cash equivalents is $1.57 million

    Accounts receivable

    $5.99M
    TBIO annual accounts receivable is $5.99 million

    Inventory

    $4.03M
    TBIO annual inventory is $4.03 million

    Liabilities

    Total liabilities

    $40.87M
    TBIO annual total liabilities is $40.87 million

    Long term liabilities

    $32.69M
    TBIO annual total long term liabilities is $32.69 million

    Current liabilities

    $8.18M
    TBIO annual total current liabilities is $8.18 million

    Accounts payable

    $3.28M
    TBIO annual accounts payable is $3.28 million

    Debt

    Total debt

    $34.38M
    TBIO annual total debt is $34.38 million

    Total debt 1-year change

    +60.45%
    TBIO annual total debt is up +60.45% year-on-year

    Long term debt

    $32.56M
    TBIO annual long term debt is $32.56 million

    Short term debt

    $1.82M
    TBIO annual short term debt is $1.82 million

    Equity & Capital

    Shareholders equity

    $29.54M
    TBIO annual stockholders equity is $29.54 million

    Book value

    $238.00K
    TBIO annual book value is $238.00 thousand

    Retained earnings

    -$161.47M
    TBIO annual retained earnings is -$161.47 million

    Working capital

    $22.17M
    TBIO annual working capital is $22.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$34.67M
    TBIO annual cash flow from operations is -$34.67 million

    Cash from operations 1-year change

    +10.46%
    TBIO annual cash flow from operations is up +10.46% year-on-year

    Cash from investing

    -$5.74M
    TBIO annual cash flow from investing activities is -$5.74 million

    Cash from investing 1-year change

    +68.1%
    TBIO annual cash flow from investing activities is up +68.1% year-on-year

    Cash from financing

    $11.56M
    TBIO annual cash flow from financing activities is $11.56 million

    Cash from financing 1-year change

    +156.43%
    TBIO annual cash flow from financing activities is up +156.43% year-on-year

    CAPEX

    CAPEX

    $1.98M
    TBIO annual capital expenditures is $1.98 million

    CAPEX 1-year change

    -55.68%
    TBIO annual capital expenditures is down -55.68% year-on-year

    Free Cash Flow

    Free cash flow

    -$36.65M
    TBIO annual free cash flow is -$36.65 million

    Free cash flow 1-year change

    +15.14%
    TBIO annual free cash flow is up +15.14% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    61.62%
    TBIO annual gross profit margin is 61.62%

    Operating margin

    -127.78%
    TBIO annual operating profit margin is -127.78%

    Net margin

    -173.49%
    TBIO annual net profit margin is -173.49%

    ROA & ROE

    ROA

    -62.89%
    TBIO annual return on assets is -62.89%

    ROE

    -125.42%
    TBIO annual return on equity is -125.42%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TBIO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TBIO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.03
    TBIO price to book ratio is -0.03

    PB ratio Sector rank

    13.73%
    TBIO price to book ratio is higher than 13.73% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.03
    TBIO price to sales ratio is 0.03

    PS ratio Sector rank

    2.68%
    TBIO price to sales ratio is higher than 2.68% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $29.69M
    TBIO enterprise value is $29.69 million

    Enterprise value Sector rank

    31.25%
    TBIO enterprise value is higher than 31.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.72
    TBIO EV/EBITDA is -0.72

    EV/EBITDA Sector rank

    52.77%
    TBIO EV/EBITDA is higher than 52.77% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.71
    TBIO annual current ratio is 3.71

    Quick ratio

    3.22
    TBIO annual quick ratio is 3.22

    Leverage

    Debt to equity

    0.18
    TBIO annual debt to equity ratio is 0.18

    Interest coverage ratio

    -14.36
    TBIO annual interest coverage ratio is -14.36

    Risk & Stability

    Piotroski F-Score

    2
    TBIO piotroski f-score is 2

    Altman Z-Score

    -4.52
    TBIO altman z-score is -4.52

    Analyst ratings

    Recent major analysts updates

    Aug 11, 23 Keybanc
    Sector Weight
    Nov 9, 22 Keybanc
    Overweight
    Mar 28, 22 Keybanc
    Overweight
    Jul 13, 21 Keybanc
    Overweight
    Jul 13, 21 Jefferies
    Buy
    Jul 13, 21 Cowen & Co.
    Outperform

    Institutional Ownership

    Screeners with TBIO included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Earnings today
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    • What is the ticker symbol for Telesis Bio, Inc.?
    • Does Telesis Bio, Inc. pay dividends?
    • What sector is Telesis Bio, Inc. in?
    • What industry is Telesis Bio, Inc. in?
    • What country is Telesis Bio, Inc. based in?
    • When did Telesis Bio, Inc. go public?
    • Is Telesis Bio, Inc. in the S&P 500?
    • Is Telesis Bio, Inc. in the NASDAQ 100?
    • Is Telesis Bio, Inc. in the Dow Jones?
    • When was Telesis Bio, Inc.'s last earnings report?
    • When does Telesis Bio, Inc. report earnings?

    What is the ticker symbol for Telesis Bio, Inc.?

    The ticker symbol for Telesis Bio, Inc. is NASDAQ:TBIO

    Does Telesis Bio, Inc. pay dividends?

    No, Telesis Bio, Inc. does not pay dividends

    What sector is Telesis Bio, Inc. in?

    Telesis Bio, Inc. is in the Healthcare sector

    What industry is Telesis Bio, Inc. in?

    Telesis Bio, Inc. is in the Medical Devices industry

    What country is Telesis Bio, Inc. based in?

    Telesis Bio, Inc. is headquartered in United States

    When did Telesis Bio, Inc. go public?

    Telesis Bio, Inc.'s initial public offering (IPO) was on June 18, 2021

    Is Telesis Bio, Inc. in the S&P 500?

    No, Telesis Bio, Inc. is not included in the S&P 500 index

    Is Telesis Bio, Inc. in the NASDAQ 100?

    No, Telesis Bio, Inc. is not included in the NASDAQ 100 index

    Is Telesis Bio, Inc. in the Dow Jones?

    No, Telesis Bio, Inc. is not included in the Dow Jones index

    When was Telesis Bio, Inc.'s last earnings report?

    Telesis Bio, Inc.'s most recent earnings report was on July 11, 2025

    When does Telesis Bio, Inc. report earnings?

    The date for Telesis Bio, Inc.'s next earnings report has not been announced yet
    On this page